TAF4 and neoplasm: In a cohort of males (n > 10 in each group), Taf4 loss in Taf4IEC::Apc+/Δ14 mice reduced overall survival and aggravated tumor burden compared to Apc+/Δ14 mice (Fig. 8A, B).